50mg CBD Gelpell® Capsules
A High Quality Source of CBD and cannabinoids.
Gelpell® capsules contain full spectrum hemp extract CBD in a seamless gelatine bead. This bead is placed inside a hard gastro-resistant capsule ensuring the release of CBD in the small intestine where it has the greatest effect. Manufactured in Switzerland to the highest standards under controlled laboratory conditions, every Gelpell® capsule delivers a consistent dose of cannabinoids.
Why choose CBD Gelpell® Capsules?
Gelpell® capsules have been clinically proven to improve the body’s absorption of CBD and other cannabinoids. They are easy to take and contain a consistent and precise dose of CBD. You can be confident you are taking the same dose every time.
- Gelpell® capsules protect the CBD and other cannabinoids from the damaging effects of heat, light and oxidation
- They contain full spectrum hemp extract including terpenes and flavonoids, which help improve the overall effect
- Each Gelpell® capsule delivers a precise dose of CBD
- They can be stored at room temperature
- They are made in Switzerland in accordance with Good Manufacturing Practices (GMP)
Satipharm capsules were safe for use and demonstrated a potent seizure-reducing effect among paediatric TRE patients. This result was achieved with Satipharm CBD 50mg Gelpell® capsules that do not contain the psychoactive cannabinoid THC. This is an important consideration for a treatment where patients may need to take the treatment for some months or years.
Accessing 50mg Gelpell® Capsules
Information for CBD in Australia:
Satipharm CBD 50mg Gelpell® capsules are available in Australia through the Therapeutic Goods Administration (TGA) Special Access Scheme (Category B) or through the Authorised Prescriber Scheme. Patients wishing to access medicinal cannabis products should discuss access with their physician and make themselves familiar with the processes by reading the TGA advice at www.tga.gov.au
Information for CBD in New Zealand:
Cannabidiol (CBD) is a prescription medicine under the Medicines Act 1981 in New Zealand. Ministry of Health approval is not required to prescribe, supply or administer CBD products for medical purposes.
Authorised prescribers and pharmacies can import CBD products, as are persons or companies holding a licence to sell medicines by wholesale. Importantly, Individual patients may import CBD products provided they have a valid prescription. As with all prescription medicines, patients must have a prescription from an authorised prescriber to import or use CBD products.
If you are a patient and interested in using CBD for a medical purpose, please talk to your doctor as a first step. A maximum of three months’ supply is allowed on a prescription for CBD products.
Please contact us directly at email@example.com if you would like more information or to order Satipharm Gelpell® Capsules.